Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to assess the efficacy and safety of KW-0761 after intravenous injections in subjects with HTLV-1 associated myelopathy (HAM) in Japan.


Clinical Trial Description

The effects of KW-0761 (0.3 mg/kg) on the Osame's motor disability score (OMDS) of subjects with HTLV-1 associated myelopathy (HAM). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03191526
Study type Interventional
Source Kyowa Kirin Co., Ltd.
Contact
Status Terminated
Phase Phase 3
Start date May 22, 2017
Completion date August 31, 2021